This concise, clinically focused handbook offers a complete overview of tuberculosis and reviews the latest guidelines, treatment options, clinical trials and management of this disease. Handbook of Tuberculosis is a well-rounded book written by renowned researchers at the Johns Hopkins Center for Tuberculosis Research. The easily accessible text offers infectious disease specialists, pulmonologists, and other healthcare workers an excellent quick reference tool, with full color tables and figures enhancing the text further.
Tuberculosis is a life-threatening lung infection that affects people of all ages. It is the second biggest cause of death from infectious diseases and is the most common cause of death amongst patients with HIV/AIDS. Education on the recognition of tuberculosis and the subsequent treatment of the disease is empirical to the prevention of wide-spread resistance. There is a lack of knowledge on how to treat coinfected and comorbid patients, this handbook offers the latest medical guidance and treatment options to equip physicians to manage such patients.
Richard E. Chaisson, MD, is Professor of Medicine, Epidemiology and International Health at the Johns Hopkins University in Baltimore. He received his BS and MD degrees from the University of Massachusetts, and was an intern, resident, and fellow at the University of California, San Francisco, where he was also Assistant Professor of Medicine. From 1988 to 1998 he was Director of the Johns Hopkins AIDS Service, and he co-founded the Johns Hopkins HIV Clinic cohort, an observational study that has been the source of more than 130 scientific publications on the outcomes of HIV disease and its treatment.
Dr. Chaisson is currently Director of the Johns Hopkins Center for Tuberculosis Research, a multidisciplinary center with more than $60 million in grants for the study of tuberculosis from bench to bedside. Dr. Chaisson's research interests focus on tuberculosis and HIV infection, including global epidemiology, clinical trials, diagnostics, and public health interventions. He is currently principal investigator of 11 research grants, and is director of the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), an international research consortium funded by the Bill and Melinda Gates Foundation to assess the impact of novel strategies for controlling HIV-related tuberculosis. He has published over 300 scientific papers and book chapters.
